|
1
|
Carpenter DH, El-Mofty SK and Lewis JS Jr:
Undifferentiated carcinoma of the oropharynx: A human
papillomavirus-associated tumor with a favorable prognosis. Mod
Pathol. 24:1306–1312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin YC, Wu HP and Tzeng JE: Small-cell
undifferentiated carcinoma of the submandibular gland: An extremely
rare extrapulmonary site. Am J Otolaryngol. 26:60–63. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Toyosawa S, Ohnishi A, Ito R, Ogawa Y,
Kishino M, Yasui Y, Kitamura R, Matsuya T, Ishida T and Ijuhin N:
Small cell undifferentiated carcinoma of the submandibular gland:
Immunohistochemical evidence of myoepithelial, basal and luminal
cell features. Pathol Int. 49:887–892. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niedobitek G and Herbst H: Epstein-Barr
virus-associated carcinomas. Epstein-Barr Virus Rep. 1:81–85.
1994.
|
|
5
|
Ejaz A and Wenig BM: Sinonasal
undifferentiated carcinoma: Clinical and pathologic features and a
discussion on classification, cellular differentiation, and
differential diagnosis. Adv Anat Pathol. 12:134–143. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ang KK, Harris J, Wheeler R, Weber R,
Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C,
et al: Human papillomavirus and survival of patients with
oropharyngeal cancer. N Engl J Med. 363:24–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kofler B, Laban S, Busch CJ, Lörincz B and
Knecht R: New treatment strategies for HPV-positive head and neck
cancer. Eur Arch Otorhinolaryngol. 271:1861–1867. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iezzoni JC, Gaffey MJ and Weiss LM: The
role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am
J Clin Pathol. 103:308–315. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wadsworth B, Bumpous JM, Martin AW,
Nowacki MR, Jenson AB and Farghaly H: Expression of p16 in
sinonasal undifferentiated carcinoma (SNUC) without associated
human papillomavirus (HPV). Head Neck Pathol. 5:349–354. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okano M, Thiele GM, Davis JR, Grierson HL
and Purtilo DT: Epstein-Barr virus and human diseases: Recent
advances in diagnosis. Clin Microbiol Rev. 1:300–312. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshizaki T, Takimoto T, Takeshita H,
Tanaka S, Furukawa M, Seiki M and Sato H: Epstein-Barr virus lytic
cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid
cell line. Laryngoscope. 104:91–94. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshizaki T, Kondo S, Wakisaka N, Murono
S, Endo K, Sugimoto H, Nakanishi S, Tsuji A and Ito M: Pathogenic
role of Epstein-Barr virus latent membrane protein-1 in the
development of nasopharyngeal carcinoma. Cancer Lett. 337:1–7.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshizaki T, Ito M, Murono S, Wakisaka N,
Kondo S and Endo K: Current understanding and management of
nasopharyngeal carcinoma. Auris Nasus Larynx. 39:137–144. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kreimer AR, Clifford GM, Boyle P and
Franceschi S: Human papillomavirus types in head and neck squamous
cell carcinomas worldwide: A systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goon PK, Stanley MA, Ebmeyer J,
Steinsträsser L, Upile T, Jerjes W, Bernal-Sprekelsen M, Görner M
and Sudhoff HH: HPV and head and neck cancer: A descriptive update.
Head Neck Oncol. 1:362009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vermorken JB, Psyrri A, Mesía R, Peyrade
F, Beier F, de Blas B, Celik I and Licitra L: Impact of tumor HPV
status on outcome in patients with recurrent and/or metastatic
squamous cell carcinoma of the head and neck receiving chemotherapy
with or without cetuximab: Retrospective analysis of the phase III
EXTREME trial. Ann Oncol. 25:801–807. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bonner JA, Mesia R, Giralt J, Psyrri A,
Keilholz U, Rosenthal DI, Beier F, Schulten J and Vermorken JB:
p16, HPV, and cetuximab: What is the evidence? Oncologist.
22:811–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
